We’re looking for women ages 18-42 to participate in The GRACE Study.
Interested in IVF treatment?
If you are a woman between the ages of 18 and 42 who has been diagnosed with infertility (difficulty becoming pregnant), and are pre-menopausal with regular menstrual cycles (every 21-35 days), you may be eligible for participation in this study.
Compensation
If accepted into the study, you will receive compensation for your time, out-of-pocket expenses (if any), inconvenience experienced, and for completing the study. This study includes:
Up to two FET-PGT-A of all qualified embryos (if undergoing ovarian stimulation)
All additional infertility medications are required
About the Sponsor
Granata Bio, the study sponsor, is a biopharma company focused on women’s health and infertility with the mission to bring new products to the US fertility market.
By doing so, we hope to expand access to care for every patient seeking fertility treatment.
About the Study
The GRACE Study is a multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an assisted reproductive technology (ART) cycle in women.
The study is composed of three treatment periods: Period 1 & 2: controlled ovarian stimulation cycle with PGT-A; Period 3: Frozen embryo transfer.